SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-027771
Filing Date
2023-08-07
Accepted
2023-08-07 16:08:46
Documents
77
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-20230630.htm   iXBRL 10-Q 1244972
2 EX-31.1 arwr-20230630xexx311.htm EX-31.1 9733
3 EX-31.2 arwr-20230630xexx312.htm EX-31.2 9731
4 EX-32.1 arwr-20230630xexx321.htm EX-32.1 4304
5 EX-32.2 arwr-20230630xexx322.htm EX-32.2 3879
  Complete submission text file 0001628280-23-027771.txt   7123830

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arwr-20230630.xsd EX-101.SCH 55679
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arwr-20230630_cal.xml EX-101.CAL 72650
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arwr-20230630_def.xml EX-101.DEF 263218
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arwr-20230630_lab.xml EX-101.LAB 691764
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arwr-20230630_pre.xml EX-101.PRE 481447
71 EXTRACTED XBRL INSTANCE DOCUMENT arwr-20230630_htm.xml XML 976114
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 231147679
SIC: 2834 Pharmaceutical Preparations